42Stockpicking

TNXP

Tonix Pharmaceuticals Holding Corp
NASDAQ·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
—
EV/EBITDAi
—
P/Bi
0,9
5th %ile · 404p
P/Si
9,3
69th %ile · 356p
EV/Salesi
1,8
35th %ile · 356p
Div yieldi
—

Kursudvikling

Kun 117 handelsdage i databasen. Viser al tilgængelig historik.

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 10.6.2026none
Prishistorik
0,2 år
Pris-dage
58
Årsregnskaber
19
Peers
0/0
Valuation
3/6
Fundamentals
7/8
Datovindue
2026-02-17 til 2026-05-08

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Mangler ca. 9,8 års prishistorik før ideal/full.
  • Backfill mindst 1 års daglige priser før seriøs teknisk vurdering.
  • Kør compute-multiples for manglende valuation metrics.
  • Kør fetch-fundamentals-bulk/API fallback for manglende regnskabsmetrics.

Seneste assessment

TNXP vurderet 2026-06-10

Score
42.1%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

52%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

56%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

48%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

54%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

46%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

47%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

42%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: P/E relative valuation needs both own multiple and peer median.

Insider activity

Net 90d (aktier)
12.415
Net 90d (værdi)
144.728 USD
Købere 90d
4
Cluster buy
✓
DatoPersonRolleTypeAntalVærdiKilde
20.8.2026BAGGER RICHARD H—▲ KØB1.00012.600 USDsec
30.6.2026SAENGER BRADLEYChief Financial Officer· ANDET1.45315.858 USDsec
12.6.2026Taylor Carolyn E.—▲ KØB1.41514.928 USDsec
9.6.2026LEDERMAN SETHChief Executive Officer▲ KØB5.00058.950 USDsec
8.6.2026Stillwell Richard Newcomb—▲ KØB5.00058.250 USDsec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q130.4.2026-2,93-2,54-15.3%-15.3%Miss
2025Q430.1.2026-3,98-2,94-35.4%-35.4%Miss
2025Q330.10.2025-3,70-2,75-34.4%-34.4%Miss
2025Q230.7.2025-4,00-1,88-112.8%-112.8%Miss